INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 211 filers reported holding INSMED INC in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,770,127 | +30.2% | 1,099,807 | +8.8% | 0.01% | +33.3% |
| Q2 2023 | $21,336,700 | +24.4% | 1,011,218 | +0.5% | 0.01% | +20.0% |
| Q1 2023 | $17,153,425 | -14.7% | 1,006,066 | -0.0% | 0.01% | -16.7% |
| Q4 2022 | $20,109,011 | +7.3% | 1,006,457 | +15.7% | 0.01% | -14.3% |
| Q3 2022 | $18,745,000 | +11.7% | 870,227 | +2.3% | 0.01% | +16.7% |
| Q2 2022 | $16,776,000 | -17.0% | 850,661 | -1.1% | 0.01% | 0.0% |
| Q1 2022 | $20,204,000 | -12.7% | 859,713 | +1.2% | 0.01% | -14.3% |
| Q4 2021 | $23,143,000 | +1.4% | 849,574 | +2.5% | 0.01% | 0.0% |
| Q3 2021 | $22,830,000 | +0.7% | 828,953 | +4.0% | 0.01% | -12.5% |
| Q2 2021 | $22,677,000 | -9.1% | 796,798 | +8.8% | 0.01% | -11.1% |
| Q1 2021 | $24,950,000 | +0.8% | 732,517 | -1.5% | 0.01% | -10.0% |
| Q4 2020 | $24,752,000 | +10.2% | 743,516 | +6.4% | 0.01% | 0.0% |
| Q3 2020 | $22,452,000 | +21.4% | 698,564 | +4.0% | 0.01% | +11.1% |
| Q2 2020 | $18,496,000 | +107.1% | 671,587 | +20.5% | 0.01% | +80.0% |
| Q1 2020 | $8,933,000 | -31.6% | 557,216 | +1.9% | 0.01% | -28.6% |
| Q4 2019 | $13,053,000 | +38.2% | 546,594 | +2.1% | 0.01% | +16.7% |
| Q3 2019 | $9,442,000 | -24.7% | 535,246 | +9.2% | 0.01% | -25.0% |
| Q2 2019 | $12,546,000 | -2.5% | 490,072 | +10.7% | 0.01% | 0.0% |
| Q1 2019 | $12,870,000 | +133.9% | 442,719 | +5.6% | 0.01% | +100.0% |
| Q4 2018 | $5,502,000 | -34.9% | 419,333 | +0.4% | 0.00% | -33.3% |
| Q3 2018 | $8,447,000 | -10.7% | 417,739 | +4.4% | 0.01% | -14.3% |
| Q2 2018 | $9,464,000 | +10.2% | 400,130 | +4.9% | 0.01% | 0.0% |
| Q1 2018 | $8,591,000 | -23.8% | 381,444 | +5.5% | 0.01% | -22.2% |
| Q4 2017 | $11,277,000 | +3.9% | 361,662 | +4.0% | 0.01% | 0.0% |
| Q3 2017 | $10,855,000 | +124.6% | 347,798 | +23.5% | 0.01% | +80.0% |
| Q2 2017 | $4,834,000 | -2.5% | 281,650 | -0.5% | 0.01% | 0.0% |
| Q1 2017 | $4,959,000 | +41.5% | 283,167 | +6.9% | 0.01% | +25.0% |
| Q4 2016 | $3,504,000 | -3.6% | 264,836 | +5.9% | 0.00% | 0.0% |
| Q3 2016 | $3,633,000 | +54.9% | 250,166 | +5.2% | 0.00% | +33.3% |
| Q2 2016 | $2,345,000 | -16.1% | 237,824 | +7.9% | 0.00% | -25.0% |
| Q1 2016 | $2,794,000 | -28.6% | 220,464 | +2.2% | 0.00% | -20.0% |
| Q4 2015 | $3,914,000 | +15.9% | 215,631 | +18.6% | 0.01% | 0.0% |
| Q3 2015 | $3,378,000 | +28.9% | 181,888 | +69.5% | 0.01% | +25.0% |
| Q2 2015 | $2,621,000 | +80.5% | 107,314 | +53.7% | 0.00% | +100.0% |
| Q1 2015 | $1,452,000 | +34.4% | 69,800 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $1,080,000 | +5.3% | 69,800 | -11.2% | 0.00% | 0.0% |
| Q3 2014 | $1,026,000 | -10.9% | 78,600 | +36.5% | 0.00% | 0.0% |
| Q2 2014 | $1,151,000 | +22.6% | 57,600 | +16.8% | 0.00% | 0.0% |
| Q1 2014 | $939,000 | +11.9% | 49,300 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $839,000 | +6.5% | 49,300 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $788,000 | +101.0% | 49,300 | +22.3% | 0.00% | +100.0% |
| Q2 2013 | $392,000 | – | 40,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |